| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |